LY-294002 | Experimental | ABCB1 | 5243 |
downregulated | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of ABCB1 mRNA | 7q21.12 | |
LY-294002 | Experimental | AKT1 | 207 |
downregulated | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of AKT1 mRNA | 14q32.33 | |
LY-294002 | Experimental | BCL2 | 596 |
upregulated | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of BCL2 mRNA | 18q21.33 | |
LY-294002 | Experimental | BIRC2 | 329 |
downregulated | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of BIRC2 mRNA | 11q22.2 | |
LY-294002 | Experimental | BIRC5 | 332 |
downregulated | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of BIRC5 mRNA | 17q25.3 | |
LY-294002 | Experimental | BIRC5 | 332 |
upregulated | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of BIRC5 mRNA | 17q25.3 | |
LY-294002 | Experimental | CCND2 | 894 |
upregulated | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of CCND2 mRNA | 12p13.32 | |
LY-294002 | Experimental | DDIT4 | 54541 |
downregulated | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of DDIT4 mRNA | 10q22.1 | |
LY-294002 | Experimental | FAS | 355 |
downregulated | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of FAS mRNA | 10q23.31 | |
LY-294002 | Experimental | GCLC | 2729 |
downregulated | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of GCLC mRNA | 6p12.1 | |
LY-294002 | Experimental | GCLM | 2730 |
downregulated | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of GCLM mRNA | 1p22.1 | |
LY-294002 | Experimental | GSS | 2937 |
downregulated | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of GSS mRNA | 20q11.22 | |
LY-294002 | Experimental | IGF1 | 3479 |
upregulated | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of ascorbate-2-phosphate results in increased expression of IGF1 mRNA | 12q23.2 | |
LY-294002 | Experimental | MIR21 | 406991 |
downregulated | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of MIR21 mRNA | 17q23.1 | |
LY-294002 | Experimental | MMP2 | 4313 |
downregulated | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of MMP2 mRNA | 16q12.2 | |
LY-294002 | Experimental | MMP9 | 4318 |
downregulated | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of MMP9 mRNA | 20q13.12 | |
LY-294002 | Experimental | PDCD4 | 27250 |
upregulated | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of PDCD4 mRNA | 10q25.2 | |
LY-294002 | Experimental | VEGFA | 7422 |
downregulated | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of VEGFA mRNA | 6p21.1 | |
2-Aminophenol | Experimental | AKR1C2 | 1646 |
upregulated | 2-aminophenol results in increased expression of AKR1C2 mRNA | 10p15.1 | |
2-Aminophenol | Experimental | CXCL8 | 3576 |
upregulated | 2-aminophenol results in increased expression of CXCL8 mRNA | 4q13.3 | |
2-Aminophenol | Experimental | CYP1A1 | 1543 |
upregulated | 2-aminophenol results in increased expression of CYP1A1 mRNA | 15q24.1 | |
2-Aminophenol | Experimental | HMOX1 | 3162 |
upregulated | 2-aminophenol results in increased expression of HMOX1 mRNA | 22q12.3 | |
2-Aminophenol | Experimental | NQO1 | 1728 |
upregulated | 2-aminophenol results in increased expression of NQO1 mRNA | 16q22.1 | |
o-Bromophenol | Experimental | CYP11A1 | 1583 |
upregulated | 2-bromophenol results in increased expression of CYP11A1 mRNA | 15q24.1 | |
o-Bromophenol | Experimental | CYP17A1 | 1586 |
upregulated | 2-bromophenol results in increased expression of CYP17A1 mRNA | 10q24.32 | |